Lifeway Foods, Inc.
Lifeway Foods, Inc. Q3 FY2024 earnings call
November 14, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-11-14
Management highlights
- Strong momentum continued with double-digit top-line growth, including the second largest ever quarterly net sales result driven by volume growth of Lifeway drinkable kefir.
- 20th consecutive quarter of quarterly net sales growth, marking five consecutive years of quarterly growth.
- Gross profit margin improved, with manufacturing efficiencies and fixed cost absorption driving operating leverage.
- Capital spending increased to $5.4 million over nine months to increase manufacturing capacity.
- Launched first ever 100% lactose-free labeled product, with new Organic Whole Milk Flavor Fusion items and new on-trend flavors like Hot Honey, Matcha Latte, and Passionfruit Lychee.
- Expanded distribution in South Africa and began shipping to Dubai and the UAE.
- Sponsored Charity Miles app for mental health initiatives, implemented in-store programs, and continued e-commerce and influencer partnerships.
- Farmer Cheese to gain mass market placement in 1,400 stores in Q1 2025.
Segment performance
For the third quarter ended September 30, 2024, Lifeway Foods had net sales of $46.1 million, an increase of $5.2 million or 12.7% compared to the third quarter of 2023. The double-digit growth was primarily volume driven from branded drinkable kefir. For the nine months ended September 30, 2024, net sales were $139.9 million, an 18.5% increase compared to the first nine months of 2023. Gross profit margin was 25.7% for the quarter ended September 30, 2024 and 26.2% for the nine months ended September 30, 2024, up 30 basis points compared to the same period in 2023. Year-to-date, drinkable kefir sales have increased more than 22%.
Guidance
- On pace for a new annual sales record in 2024.
- Plan to continue investing behind key products to capture more of the growing market.
- Look forward to updating on continued momentum in the year-end call in March.
Risks
- Macro headwinds including higher prices, high interest rates, and uncertain geopolitical landscape.
- Consumers budgeting carefully but prioritizing health and wellness.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.19 | $0.27 | -29.6% | — |
| Revenue | $46.1M | $47.5M | -3.0% | — |
Transcript
November 14, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.